Skip to main content

Table 3 Vaccine coverage

From: Invasive pneumococcal infections in Vellore, India: clinical characteristics and distribution of serotypes

 

Vaccines

<2 yrs

2-17 yrs

18-59 yrs

≥60 yrs

All ages

 

PCV7

23 (49%)

18 (36%)

19 (17.0%)

10 (29%)

70 (28.7%)

 

PCV10

28 (60%)

29 (58%)

50 (44.6%)

21 (60%)

128 (52.5%)

 

PCV13

32 (68%)

35 (70%)

63 (56.2%)

27 (77%)

157 (64.3%)

 

PCV15*

33 (70%)

37 (74%)

64 (57.1%)

28 (80%)

162 (66.4%)

 

PPV23**

33 (70%)

41 (82%)

75 (67.0%)

29 (83%)

178 (73.0%)

Total

 

47

50

112

35

244

  1. Number (percent) of strains covered by PCV-7, -10, -13, the coming PCV15 and the PPV23 in different age groups and all ages. N=244 *PCV15 includes all PCV13 serotypes, 22 F and 33 F. **Pneumococcal polysaccharide vaccine 23, includes serotypes 1, 2, 3, 4, 5, 6B, 7 F, 8, 9 N, 9 V, 10A, 11A, 12 F, 14, 15B, 17 F, 18C, 19A, 19 F, 20, 22 F, 23 F, 33 F.